glp-1/fgf21 agonist boehringer Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists Evolution of GLP‐1 Receptor Agonists

Marsico F, Paolillo S, Gargiulo P, Bruzzese D, DellAversana S, Esposito I, Renga F, Esposito L, Marciano C, Dellegrottaglie S, Iesu I, Perrone Filardi P

31 , 351362 e355 (2020)

A linear regression analysis for the change from baseline to 6 months of the MHFMS, including age at study entry and treatment group as independent variables, indicates that age has a borderline effect on change (p = 0.0564), but treatment was not significant at p = 0.0912

Patients who smoke are strongly advised to quit as this habit increases the strain on the cardiovascular system and can exacerbate symptoms of lupus

Davies, M.J., et al., CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Multiple pain mechanisms may be active at the same time in the single patient, making diagnosis and treatment more difficult (Freynhagen et al., 2019)